Clinical Trial Update: A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a [Phase 4]

View source ↗

Summary

A Phase 4 proof-of-concept study evaluating retinal nerve fiber layer changes in relapsing-remitting multiple sclerosis patients treated with Natalizumab or Int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)
• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 4 | Status: WITHDRAWN